DUBLIN--(BUSINESS WIRE)--The "Sevoflurane Market, by Application, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering. This report provides an in-depth analysis of global sevoflurane market, provides market size (US$ Million), and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year. Market DynamicsMarket players are focused on launching new technology to help delivery of anesthesia through inhalers, this could contribute to the growth of the global sevoflurane market over the forecast period. Increasing number of aesthetic surgeries requiring anesthesia, is expected to drive the growth of global sevoflurane market. Detailed Segmentation:Global Sevoflurane Market, By Application:InductionMaintenanceGlobal Sevoflurane Market, By Distribution Channel:Hospital PharmaciesRetail PharmaciesOnline PharmaciesGlobal Sevoflurane Market, By Region:North AmericaU.S.CanadaLatin AmericaBrazilMexicoArgentinaRest of Latin AmericaEuropeU.K.GermanyItalySpainFranceRussiaRest of EuropeAsia PacificChinaIndiaJapanAustraliaSouth KoreaASEANRest of Asia PacificMiddle EastGCCIsraelRest of Middle EastAfricaSouth AfricaCentral AfricaNorth AfricaCompany ProfilesAbbott LaboratoriesBaxterPiramal Pharma SolutionsManus Aktteva Biopharma LLPMaruishi Pharmaceutical Co.,Ltd.

Source: The North Africa Journal June 29, 2022 09:55 UTC